Exponential Surge of North America to Contribute to Health Information Exchange Market

Health information exchange infrastructure is being developed for data distribution and sharing between providers and also to support the sharing of the health information records across providers in various geographic regions of the country. Health information exchange will drive the sharing of the data amongst the providers and health systems via the Nationwide Health Information Exchange Network. HIMSS is actively engaged in the development of Health information exchanges and HIMSS also provides a wide range of tools and statistical resources for interested professionals across the globe in Health information exchange. Health information exchange permits doctors, nurses, pharmacists, providers and patients to accurately and securely access and share any vital health information through Health information exchange with speed, safety, and quality.

A sample of this report is available upon request @

http://www.persistencemarketresearch.com/samples/16435

Although Health information exchange is widespread available, a maximum number of medical information is stored on paper. Sharing of these medical information happens through fax or emails or by the patients themselves. Health information exchange can’t substitute the patient-provider communication, but it can surely increase the completeness of the patient’s records which will have the patient’s history, present medications, and other health-related information. Timely sharing of important patient information can help in decision making in critical times. Patient information transfer through Health information exchange can avoid readmissions, medication errors will improve diagnoses and will even reduce duplicate testing. Like for example, if Lab results are obtained electronically through health information exchange and incorporated into a provider’s Electronic health records, a list of patients will directly be generated, the provider can schedule necessary follow-ups with the patients and arrange appointments regarding medication.

Health Information Exchange Market: Dynamics

Health information exchange market has many driving factors at its end. Decentralized treatments and increasing incidences of cardiac arrests will enhance the health information exchange market.

To view TOC of this report is available upon request @

http://www.persistencemarketresearch.com/toc/16435

Health information exchange market is increasing due to the usefulness during the emergency cases where the doctors need to know the patient’s history and medications to start new treatments for any new disease observed. Restraining factors of the Health information exchange market may be the data breaches. Data breaches in the health information exchange can be dangerous as the data can be obtained by anybody and can be mis-utilized. Health information exchange market is not available at all hospitals and clinical laboratories across therefore it will not be available for all. The main opportunity in the health information exchange market is that it can be integrated with different operating systems at the hospitals, labs, and clinics. Health information exchange systems can be integrated with revenue cycle management and core administration. Advanced technology can pose to be the threat to the health information exchange market.

Health Information Exchange Market: Region-wise Outlook

North America has the largest market share of the health information exchange market, trailed by Europe and Asia Pacific. The Greater share of the health information exchange market in North America is attributed to the rising figures of accountable care organizations in US and Canada to increase the healthcare facilities. Furthermore, Asia Pacific health information exchange market is projected to grow at the highest growth rate.

Health Information Exchange Market: Key Players

Allscripts Healthcare Solutions, Inc. (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), NextGen Healthcare Information Systems, Covisint Corporation (U.S), RelayHealth Corporation (U.S.), Optum, Inc. (U.S.), Epic Corporation Inc. (U.S.), Orion Health (New Zealand) and eClinicalWorks (U.S.) are selected key players in the health information exchange market globally.

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Persistence Market Research.

Buy Now: You can now buy a single user license of the report @

http://www.persistencemarketresearch.com/checkout/16435

 

Cell-Free DNA (cfDNA) Testing Market Size to Expand Significantly

Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.

A sample of this report is available upon request @

http://www.persistencemarketresearch.com/samples/16249
Cell-Free DNA (cfDNA) Testing Market: Drivers and Restraints

The cell-free DNA testing market is segmented by its application, types, and region. By application, the market is segmented into oncology, gynecology, and transplantation. By type, the market is further segmented into donor-derived cell-free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA) and cell-free fetal DNA (NIPT). Donor-derived cell-free DNA testing examines the graft rejection in transplanted patient by recognizing the absence or presence of donor DNA in the bloodstream. In ctDNA testing, circulating tumor DNA in urine, saliva or blood of tumor patients is examined to detect the mutation. In prenatal testing, the chromosomal abnormality is identified in the fetus by the collection of blood sample from pregnant women who carry DNA of that fetus.

Cell-Free DNA (cfDNA) Testing Market: Segmentation

The cell-free fetal DNA market has a major share in the market due to increased number of pregnancies following to it is the circulating cell-free tumor DNA market, and later the donor-derived cell-free DNA market. In the region wise segmentation, North America region had the largest revenue in 2015 due to the majority of tests launched and adaptation of advanced technologies in screening techniques. Following North America is Europe and Asia Pacific which are also the fastest growing market due to growing economy and improving healthcare infrastructure and rising prevalence of diseases in these regions. The potential of cell-free DNA testing market has attracted many biotechnology and pharmaceutical firms by acquiring other major firms or by launching novel tests.

To view TOC of this report is available upon request @

http://www.persistencemarketresearch.com/toc/16249

Cell-Free DNA (cfDNA) Testing Market: Region-wise Outlook

Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market. However, there are some other factors such as lack of skilled healthcare professionals, high test cost, non-affordability in low-income countries, ethical issues related to genetic testing, lack of standardization, unfavorable reimbursement policies and legal and regulatory guidelines some of the reasons hampering the growth of the market.

Cell-Free DNA (cfDNA) Testing Market: Key Players

Various companies are coming up with new software and improved sequencing technologies which have improved the test quality with accurate and rapid results. Some of the leading players in cell-free DNA testing market are Agilent Technology, Allenex AB, Biocept, Inc., Biodesix, Inc., CareDx, Inc. Guardant Health, Inc., Illumania, Inc., Invited Limited, Natera, Inc., Quest Diagnostics, Roche Holdings AG, Sequenom, Inc. and Trovagene, Inc. The global cell-free DNA testing market is a competitive market, and all the players are involved in developing new assays by mergers and acquisitions to sustain themselves in the market and maintain their market share. For instance, Roche Holdings AG received U.S. FDA approval for its newly launched ctDNA test Cobas which is approved for blood-based genetic tests. Roche also entered the NIPT market with the acquisition of Ariosa Diagnostics. CareDx, Inc., acquired Allenex AB for its new developments in donor-derived Cell-Free DNA tests for kidney and heart transplant patients.

Buy Now: You can now buy a single user license of the report @

http://www.persistencemarketresearch.com/checkout/16249

Traditional Chinese Medicine Market Predicted to Surpass (Revenues/Values) by the End of 2025

Traditional Chinese medicine is a holistic and natural medicine system originated thousand years ago in the ancient China. In traditional Chinese medicine, the understanding of the universe as described in the Daoism and the treatment of illness is primarily based on the analysis and syndrome differentiation. In traditional Chinese medicine, the herbal medicines, mind and body practices such as acupuncture, tai chi, massage therapy and nutrition therapy is used to the treat the various diseases and disorders. The diseases and disorders include fatigue, chronic pain, infertility, headache, and hormonal Imbalances and others. The traditional Chinese medicine therapy is worldwide accepted as a complementary health approach.

A sample of this report is available upon request @
Buy Now: You can now buy a single user license of the report @

The traditional Chinese medicine is formed by the thousand years of experience of maintaining health, understanding life and treating the daily life diseases. The traditional Chinese medicine is also used for prevention of diseases, which boost the demand for the traditional Chinese medicine therapy and propel the growth of the market over the forecast period.

The global traditional Chinese medicine treatment market is segmented on the basis of therapy type, and application.

To view TOC of this report is available upon request @

http://www.persistencemarketresearch.com/toc/16219

The global traditional Chinese medicine treatment market is expected to register a significant CAGR over a forecast period. The increasing acceptance of traditional Chinese medicine as a primary health approach in the western countries such as U.S. and Canada and other developed economies is the major factor, which anticipated to boost the growth of the global traditional Chinese medicine treatment market. The traditional Chinese medicine treatment addresses the patient-external factors and environment and helps patient to manage stress by improving lifestyle factors such as routine of diet and exercise which also fuel the demand for the traditional Chinese medicine and drives the growth of the global traditional Chinese medicine market. The traditional Chinese medicine also protects cognitive health, preserves strength and flexibility of the patient, also propels the demand for the traditional Chinese medicine and drives the market growth over the forecast period.

However, some herbal products used in traditional Chinese medicine may not be safe and have an adverse effect on the patient which may hamper the demand for the traditional Chinese medicine and restrain the growth of the global traditional Chinese medicine market. The safety of the other traditional Chinese medicine is the major concern as it reported the complications such as allergic reactions, infections, and burns also may restrain the growth of the global traditional Chinese medicine market. The U.S. FDA regulations and European Committee guidelines also may affect the demand for traditional Chinese medicine and restrain the growth of the global market of traditional Chinese medicine over the forecast period.

On the basis of regional presence, the global traditional Chinese medicine treatment market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa.

The Asia Pacific is dominating and contributed the leading shares to the global traditional Chinese medicine treatment market in terms of revenue and expected to register a significant growth over a forecast period due to the practice in the origin country and availability of treatment facilities for the same in the region. The North America and Europe have also contributed the moderate shares and registered a healthy growth rate to the global Traditional Chinese medicine treatment market due to increasing acceptance of traditional Chinese medicine as a primary level treatment. The Latin America and MEA are at a nascent stage to the global traditional Chinese medicine treatment market and expected to show a moderate growth over a forecast period.

Some of the market players in Traditional Chinese Medicine Treatment Market globally include Misha Ruth Cohen, TCM Australia, ACTCM, Sacred Lotus, Medical Qigong Centre & Acupuncture Clinic, ICTCM House, Dublin Chinese Medicine Clinic, ChinaMed Charlottesville, NZ Chinese Medicine & Acupuncture Society and Healthy Lifestyle Brands, LLC.

Buy Now: You can now buy a single user license of the report @

http://www.persistencemarketresearch.com/checkout/16219

Cleanroom Doors Market Rugged Expansion Foreseen during 2016 – 2025

Revenue cycle management is the process of managing claims process, payment and revenue generation. Revenue cycle management improves access management, improving payer performance and accelerating cash collection. It also provides real time access to claim management and allows companies and hospitals to manage their work in proper channel during registration, scheduling and payment and claim processing. Revenue cycle management helps a medical practice to increase their revenue by proper claim management. There are four key player involved in the revenue cycle management of healthcare system: patients, healthcare providers, billing company and insurance provider.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/13552

Hospital revenue cycle management includes all clinical and managerial functions related to the management, collection of patient care revenue, and generation. In Revenue cycle management, the claims are being processed faster, there is a prompt denial management and the resolution rate of claims processing is around 99%. This allows the clients to experience increased cash flow and decreased claims in accounts receivable. Revenue cycle management solutions allows to monitor key business segment at any point of time, identify areas for improvement and increasing the revenue of the hospital/organization. Increase revenue generation, increased efficiency, accuracy and access of healthcare IT systems are the factors likely to drive the market in the forecast period. With the rising administrative and operational costs of the healthcare organizations, managements need to find cost-effective alternatives in order to sustain in the market. Revenue cycle management offers viable solutions by replacing the traditional paper-based systems to optimize cost.

To view TOC of this report is available upon request @http://www.persistencemarketresearch.com/toc/13552

The revenue cycle management market has been segmented by platform, by deployment, by solutions, by end-user and by geography. In terms of product, the revenue cycle management market has been categorized into integrated and standalone systems. Based on deployment, the market has been segmented into cloud-based and on-premise. Based on solutions, the market has been segmented into out-source and in-house. In-house segment is further classified into hardware, software and services. Based on end-user, the market has been segmented into provider and payers. Provider segment is further classified into hospitals, ambulatory surgical centers & clinics and other segment. Whereas payers segment is further classified into insurance companies, government agencies and others.

Buy Now: You can now buy a single user license of the report @http://www.persistencemarketresearch.com/checkout/13552

Geographically, revenue cycle management market can be segmented into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America. North America was observed to be the largest revenue cycle management market owing to the favorable government policies, increased incentives and fastest adaptation of revenue cycle management. Countries such as the U.S. and Canada have been successful in implementing healthcare IT in their healthcare system, which as a result would boost the market growth. Moreover, presence of developed IT and healthcare infrastructure, promising government initiatives in executing revenue cycle management, highly regulated and maintained regulatory framework, and continued innovation in the region would further propel the market growth. Europe was observed to be the second largest market in the revenue cycle management owing to enhanced digitization and increasing focus on data integration, data quality, management and data governance.

Confocal Microscope Market Estimated to Reach (Revenues) by 2025

Confocal microscopes are advanced versions of conventional optical microscopes that can provide a true three-dimensional (3D) optical resolution. In a confocal microscope, the final image occupies the same focus as the focus related to the point of focus in the object, hence the object and its image are said to be confocal. Confocal microscopes offers ample advantages when compared to conventional microscopes including reformed depth of field, no out-of-focus flare and serial optical sections from thick specimens. Confocal microscopes have wide applications in the field of biomedical sciences. One of the major application is imaging of fixed or living cells and tissues labelled with one or more fluorescent probes. The major components of confocal microscopes include lasers, used as light sources to produce extremely bright light at very specific wavelengths, highly sensitive photomultiplier-detectors (PMTs) as imaging devices and microcomputer to control the microscope’s scanner mirrors. Confocal microscopes have proved their immense importance in the field of medical sciences in the areas of diagnosis, treatment and development of biomaterials.

A sample of this report is available upon request @

http://www.persistencemarketresearch.com/samples/16174

The factors driving the growth of the global confocal microscope market include wide range of applications, novel diagnosis and treatment methodologies. Rising demand of efficient tools for early diagnosis of chronic and life threatening disorders have pushed the growth rate of market up. Support of governments in terms of financial grants to improve the overall healthcare services has favored the market growth. Expanding research and development in various technical fields has also fuelled the market growth rate. However, there are factors which can limit the growth of market, which include harmful high-intensity laser irradiation to living cells and tissues, technological complexities associated with highly sophisticated equipment, dearth of trained and expert professionals and unaffordable high cost.

Global Confocal Microscope market has been segmented on the basis of technology, applications, end user and region.

Global Confocal Microscope market is highly fragmented due to presence of numerous players. The overall market is expected to witness a significant rise owing to governments’ commitments to provide better and affordable healthcare services. Integration capacities of these devices with other imaging technologies have made them more useful and user friendly leading to their market growth. Rising caseload of chronic diseases such as diabetes, hypertension, respiratory disorders such as asthma and COPD and pain and life threatening diseases such as cancer will boost the market growth globally as confocal microscopy is useful in the diagnosis and treatment both. According to the statistics availed by the World Health Organization (WHO), cancer caused 8.8 million deaths in 2015, 17.5 million people die of cardiovascular diseases and over 3 million people die of COPD annually across the globe. Most of these deaths are reported in low and middle income countries.

To view TOC of this report is available upon request @

http://www.persistencemarketresearch.com/toc/16174

Geographically, Confocal Microscope market is segmented into regions viz. North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America is currently the leader of the global market followed by Europe because of the presence of major confocal microscope players and research and development in the field. Japan is a leader in Asia because of development of confocal microscope technology. The market in Asian countries will witness rapid growth because of a large patient pool in need of services of such technologies. The governments in the region are focused on improvement of overall healthcare services, which will contribute to the market growth ultimately.

The key players in the global Confocal Microscope market include NIKON INSTRUMENTS INC., Leica Microsystems, ZEISS, Olympus Corporation, Oxford Instruments, Thorlabs, Inc., KEYENCE CORPORATION, Bruker, IDEX Health & Science, LLC, Applied Precision Inc., Confovis Gmbh, Solarius Inc and Confocal.nl.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Buy Now: You can now buy a single user license of the report @

http://www.persistencemarketresearch.com/checkout/16174

Immunofluorescence Assays Market Size will Grow at a Lucrative CAGR through 2025

Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc. Two types of immunofluorescence assays are usually performed: Direct and Indirect immunofluorescence. Direct immunofluorescence used less often as the antibody against the molecule of interest is conjugated chemically to a fluorescent dye, so to spot every antigen, the specific antibody will have to be conjugated with FITC. In indirect immunofluorescence assay, the antibody specific for the molecule of interest i.e. the primary antibody is not labeled, and the second anti-immunoglobulin antibody focused toward the first antibody i.e. the secondary antibody is tagged with some fluorescent dye. Indirect fluorescence is used more commonly as the tagged secondary antibody and can be used to detect many different antigens. However, the primary antibody will have to be specific for the antigen to be detected.

A sample of this report is available upon request @

http://www.persistencemarketresearch.com/samples/16096
The fluorescence can be read as a qualitative result or quantitative result using fluorescence microscopy. The fluorescence can also be quantified using a flow cytometer, array scanner or automated imaging instrument.

Immunofluorescence assays Market: Drivers & Restraints

The improved versions of kits and reagents increases its demand. Increase in the number of cancer incidences and various infectious diseases rising the demand. Investments in research by various governmental and non-governmental organizations is upsurging the demand for these kits. Some of the restraining factors include the potential of cross reactivity, lower signal and higher costs of kits. Introduction of more safer and cost effective tests which diverting the preference of clinicians and researchers from immunofluorescence assays.

Immunofluorescence assays has demand in both the research as well as clinical diagnostics purposes. Market includes various antibodies, regents, kits, microscopes, labeling dyes etc. Immunofluorescence preparations can be analyzed by various microscopy techniques such as Epifluorescence, TIRF, and GSDIM depending on the type of application it is used for. Thus, with the increase in immunofluorescence assay, need of fluorescence microscopy increases. Technological development, expansion in the field of immunofluorescence assays, commoditization of products and strong network of distributors at global and regional level also contributing to the growth of market.

To view TOC of this report is available upon request @

http://www.persistencemarketresearch.com/toc/16096

A geographic condition regarding the Immunofluorescence assays market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. High incidences of chronic and infectious diseases, laboratory automation, improved technology and favorable reimbursement scenario are some of the factors which have led North America dominating the immunofluorescence assay market. It is followed by Europe and most of the market in Germany. Asia Pacific is increasing in the immunofluorescence assay market because of the increasing number of market players and rising demand of improved products in diagnostics as well as academic purpose. India, China and Japan are the countries with highest growth rate in Asia Pacific region and increases the chances of business opportunities in these sectors.

Some of the global key players in the Immunofluorescence assays market for manufacturing kits and reagents for diagnosis are Thermofischer, Biorad, Universla Biologicals, Perkin Elmer, Maxvision Biosciences Inc., Euro Diagnostica, Sigma Aldrich and others. Some companies involves in the fluorescence microscope market includes Olympus lifescience, Leica Microsystems, EuroImmun AG.

Buy Now: You can now buy a single user license of the report @

http://www.persistencemarketresearch.com/checkout/16096

 

Ancient & Specialty Grain Flour Market Steady Growth to be Witnessed during 2017 – 2025

Ancient & specialty grains include gluten-free non-wheat grains such as teff, spelt, quinoa, millet, kamut, buckwheat, barley, and amaranth. The global ancient & specialty grain flour market is expected to grow at a significant growth rate, attributed to high demand for the ingredient in the product across the segments of food & beverages industries including bakery, confectionary, ready-to-eat products, etc.

A sample of this report is available upon request @  http://www.persistencemarketresearch.com/samples/17386

Global Ancient & Specialty Grain Flour Market: Dynamics

High preference for organic and gluten-free products among the consumer across the globe is one of the crucial demand side factor driving the ancient & specialty grain flour market over the forecast period. Other factors fuelling the global ancient & specialty grain flour market include rising prevalence of lifestyle diseases and coeliac diseases among the aging population. Growing demand products such as for ready-to-eat, bakery, confectionary, etc. is expected to create high impact over the growth of global ancient & specialty grain flour market. However, the high cost of isodecyl citrate is expected to restrain its growth in developing economies such as the Middle East and Africa and Asia Pacific. Merger & acquisition among the end-user including bakery manufacturers, confectionary manufacturers, and other food producers and ancient & specialty grain flour suppliers are the trending factors in global ancient & specialty grain flour market over the forecast period. Moreover, companies manufacturing ancient & specialty grain flour products can leverage potential opportunities in regions such as North America, Europe, and Asia Pacific, attributed to increasing per capita income as well as growing population.

To view TOC of this report is available upon request @http://www.persistencemarketresearch.com/toc/17386

Global Ancient & Specialty Grain Flour Market: Segmentation

The global ancient & specialty grain flour market is segmented on the basis of application, end-use, source, and region. Among the product type segments, non-wheat grains segment is expected to dominate the global ancient & specialty grain flour market, attributed to high demand for the gluten-free products across the globe. On the basis of end-use, confectionaries segment is expected to dominate the global ancient & specialty grain flour market followed by bakery segment. Whereas, ready-to-eat products segment is expected to expand at a relatively high growth rate in global ancient & specialty grain flour market over the forecast period. Among the product type segments, cereals segment is expected to dominate the global ancient & specialty grain flour market across the globe.

Based on the product type, the global ancient & specialty grain flour market is segmented into:

  • Non-wheat Grains Flour
  • Rye Flour
  • Barley Flour
  • Other Flour (teff, spelt, quinoa, millet, kamut, buckwheat, amaranth, etc.)

Based on the end-use, the global ancient & specialty grain flour market is segmented into:

  • Bakery
  • Confectionary
  • Ready-to-eat Products
  • Others

Based on the source, the global ancient & specialty grain flour market is segmented into:

  • Legumes
  • Cereals

Global Ancient & Specialty Grain Flour Market: Regional Overview

On the basis of geography, the global ancient & specialty grain flour market is fragmented into seven regions namely, North America, Asia Pacific excluding Japan (APEJ), Western Europe, Eastern Europe, Latin America, the Middle East & Africa and Japan. The North America market is expected to dominate global ancient & specialty grain flour market in terms of revenue share over the forecast period followed by Western Europe ancient & specialty grain flour market, attributed to increasing consumer preference for gluten-free ready-to-eat products. Whereas, Asia-Pacific is expected to expand at a relatively significant growth rate in the global ancient & specialty grain flour market over the forecast period, owing to increasing per capita income and rapid growth rate processed food market in the region. The Middle East & Africa, Eastern Europe, and Latin America are expected to represent a moderate opportunity in the global ancient & specialty grain flour market, owing to the moderate economic and industrial development in the region. Overall, the outlook for the global ancient & specialty grain flour market is positive over the forecast period, attributed to the preference for limited gluten intake in the daily diet by the wide population across the globe.

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/17386

Global Ancient & Specialty Grain Flour Market: Key Players

Some of the players identified in the global ancient & Specialty grain flour market include Limagrain, The Hain Celestial Group Inc., Associated British Foods PLC., General Mills, Inc., Hain Celestial Group Inc., Parrish and Heimbecker, Enjoy Life Foods LLC, The Scoular Company, Cargill Inc., Sunopta Inc., and Agrana Beteiligungs-AG.

Hip Resurfacing Implants Market set to Witness an Uptick by 2021

Hip resurfacing techniques are used to treat hip fractures while avoiding total hip replacement procedure. Hip resurfacing involves fixing of hollow mushroom shaped cobalt chrome metal cap on the surface of femur and cobalt chrome metal cup in the pelvis socket. Hip resurfacing surgery involves lesser bone removal as compared to total hip replacement surgery and reduced risk of hip dislocation. Hip resurfacing surgery is commonly performed on patients suffering from severe osteoarthritis.

A sample of this report is available upon requesthttp://www.persistencemarketresearch.com/samples/5438

Healthcare professionals prefer hip resurfacing surgery over total hip replacement surgery due to advantages of this technique over total hip replacement surgery. Preference given by healthcare professionals to hip resurfacing surgery and innovations in the hip surgery industry is driving the growth of hip resurfacing implants market. While high standards for approval of any new product to launch into the market, emerging alternative technologies and intense competition between market players are restraining growth of this market.

To view TOC of this report is available upon request @http://www.persistencemarketresearch.com/toc/5438

Mergers and acquisitions taking place in the market is one of the major developmental feature of hip resurfacing implants market that has resulted into intensive market consolidation and high competitive rivalry among the existing players. Based on the type of

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/5438

Currently, North America dominates the hip resurfacing implants market followed by Europe. The European hip resurfacing implants market is growing at slower rate due to ongoing economic upsets in the region. Asia-Pacific is a lucrative region market considering factors such as increasing healthcare spending and improving healthcare infrastructure. Some of the major companies contributing to global hip resurfacing implants market are DePuy Orthopaedics, Inc., Medtronic, Inc., Biomet, Inc., Acumed LLC, Biotronic and Smith and Nephew Plc.

Goat Cheese Market to Record Sturdy Growth during 2017 – 2025

Cheese is an old dairy product prepared from milk of cow, sheep and goat. In the last decade or two, goat cheese has grown up as the most promising market worldwide. Goat cheese is great for digestion and provides low calories unlike bovine cheese which is heavy to digest, high in cholesterol and fat. Goat cheese also contains more vitamins especially vitamin A, B1, B2, B3 and is rich in Calcium and Phosphorous. Goat cheese also provides sufficient amount of Proteins. Over the years the market has evolved from consuming bovine cheese to goat cheese. However, one of the major restraints in the market is the shorter shelf life of these products. Goat cheese is highly perishable product, can sustain maximum 60-90 days. Advances in the technology has been evolving over the years to keep it intact and maintain its flavor.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/17227

Global Goat Cheese Market: Drivers and Restrains

The fastest growing market for goat milk is majorly in the production of cheese owing to its increasing demand. Most of the manufacturers for goat cheese are based in US. The volume produced is small and almost half of the raw material is consumed for the production of the cheese and are imported. Further, U.S. goat cheese manufacturers been able to compete well in the gourmet market of cheese and have also received multiple gold medals in the international market. There are more than 100 manufacturers of goat cheese in US, which includes both artisanal and commercial goat cheese manufacturers. Consumers are preferring artisanal goat cheese owing to the factor such as artisanal producers tend to raise their own goats and utilize the milk to further process into end products such as cheese, yogurt, and others.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/17227

Due to change in food habits, there is growth in obesity and cholesterol issues across the globe. Consumers are becoming health conscious day by day, leading to increasing in demand and consumption of goat cheese. Goat cheese has come up as a significant alternative to bovine cheese and is anticipated to grow at an accelerated rate during the forecast period. Moreover, technological advancement in production of cheese, and increasing quality breeds of goat are few factors driving the market.

However, the goat cheese are expensive than any other cheese available in the market and this is one of the major restraint for the growth of market. Another restraint in the market is the challenging process. Goat cheese is made at very low temperatures with a desired quantity of rennet used therefore a proper care has to be taken while preparing goat cheese. Goat cheese is also highly perishable in nature.

Global Goat Cheese Market: Segment Overview

The global goat cheese market is segmented into product type, flavour, form, distribution channel, and regions. Further, on the basis of form, the market is sub segmented into, soft cheese, semi-soft cheese, firm cheese, ripened cheese, and aged cheese. Soft cheese is expected to dominate the market.

Global Goat Cheese Market: Regional Overview

Geographically, the goat cheese market is segmented into seven regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). Eastern Europe especially France is leading the global goat cheese market production owing to its traditional Dairy industries. Greece, Italy, Spain also has a substantial production of goat cheese. North America is the second largest contributor to the global goat cheese markets mainly due technological advancements in the production process in goat cheese. North America also raises the best quality of goat breeds, and so the cheese produced from this milk is also of best quality. Cheese market in Asia Pacific has grown tremendous over the years as a result of population growth in India and China, change in their food habits and increase in consumer spending thus lead to higher consumption of goat cheese. The Middle East and Africa are demonstrating an increased use of cheese mostly the processed cheese.

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/17227

Global Goat Cheese Market: Key Players

Some of the players identified across the value chain of the goat cheese market are:

  • Carmelis Goat Cheese
  • Haystack Mountain Goat Dairy
  • Montchevre
  • Laura Chenel’s Chèvre, Inc.
  • Cherry Glen Goat Cheese Co.
  • Avalanche Cheese Company
  • Amsterdam Cheese Company
  • DeJong cheese company
  • Hillsborough Cheese Company

Few of the strategies adopted by the key players in the market are partnership and collaboration with other operators, expansion into the untapped market, and joint ventures with the organizations in emerging countries to gain the strong foothold in the market. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, and application.

Plant-Based Protein Market Significant Profits Estimated to be Generated during 2016 – 2026

Plant-based protein also used as skin care and hair care ingredients in the cosmetics and personal care industry. Currently, demand for low-carbohydrate, and high-protein functional ingredients are increasing, hence, plant-based protein market is expected grow in the near future.

A sample of this report is available upon requesthttp://www.persistencemarketresearch.com/samples/10283

Global Plant-Based Protein Market Segments:

On the basis of source plant-based protein market is segmented into nuts and seeds, beans, grains, vegetables, non-dairy milks, and others for instance, avocado, sapote, cherimoya, and durian.

Further nuts and seeds segment is sub-segmented into chia seed, hemp seed, flax seed, sunflower seed, almond, pumpkin seed, sesame seed, and others includes pistachios, brazil nut, hazel nut, and walnut. Chia seed sub-segments contains highest protein among all the sub-segments of nuts and seeds segments.

Beans segment is sub-segmented into lentil, adzuki, cranberry beans, cannellini beans, and other include navy beans, anasazi beans and black beans. Lentil sub-segments contains highest protein among all the sub-segments of beans segments. Grains segment is sub-segmented into triticale, millet, oat and bran, wild rice, rye berries and others including bulgar wheat, and buckwheat. Triticale sub-segments contains highest protein among all the sub-segments of grains segments.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/10283

Vegetables segment is sub-segmented into corn, potato, mushroom oyster, peas, broccoli and others includes fennel, and kale. Corn sub-segments contains highest protein among all the sub-segments of vegetable segments. Non-dairy milk segment is sub-segmented into soy milk and almond milk. Soy milk sub-segments contains highest protein among all the sub-segments of non-dairy milk segments.

On the basis of application plant-based protein market is segmented into food and beverage industry, feed industry, cosmetics and personal care industry and pharmaceutical industry. Food and beverage segment contributes highest revenue in the global plant-base protein market among all the application segments. Food and beverage segment can be sub-segmented into protein supplement, protein bars, sports drinks, and others. Protein supplement is a common and popular medium among the consumers to consume plant-based protein.

Buy Now: You can now buy a single user license of the report @http://www.persistencemarketresearch.com/checkout/10283

Geographically, plant-based protein market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Middle East and Africa, and Japan. North America, Western Europe and japan are the lucrative market for the plant-based protein, owing to increasing the health consciousness.

Global Plant-Based Protein Market Dynamics:

Growing awareness of the benefits of plant-based protein and its sources are one of the major growth drivers of global plant-based protein market; moreover, recently, health consciousness that spreading over the developing countries is another factor of that increases global plant-based protein market in terms of revenue. Increasing application of plant-based protein through fortification also helps to grow the global plant-based market in terms of value, for instance use of plant-based protein ingredients grow in fortified beverages.

Substitute sources of protein such as animal based protein and synthetic protein create restrains to global plant-based protein market to grow. For instance, presently, laboratory made amino acid synthesis and protein compensation are proffering in feed industry.

Increasing demand for natural and organic products there is a high opportunity for plant-based protein in the world. Moreover, geographically Asia-pacific region for plant-based protein is anticipated grow at a significant rate in terms of value, hence there is a substantial opportunity to increase the revenue of plant-based market share by penetrating with its various applications.

Global Plant-Based Protein Market Key Players:

Some of the key players operating in the global plant-based protein market are Archer Daniels Midland Company, Cargill, Incorporated, E. I. du Pont de Nemours and Company, Fonterra Co-Operative Group, Kerry Group plc , Beyond Meat, Sun Brothers, LLC., Vega, AMCO Proteins, Hilmar Cheese Company, Inc., and Omega Protein Corporation.